Detalles de la búsqueda
1.
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Oncologist
; 25(11): 954-962, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812320
2.
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992093
3.
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
Sci Rep
; 12(1): 11007, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773363
Resultados
1 -
3
de 3
1
Próxima >
>>